novo 14 Pill - white oval, 14mm
Generic Name: semaglutide
Pill with imprint novo 14 is White, Oval and has been identified as Rybelsus (formulation R1) 14 mg. It is supplied by Novo Nordisk.
Rybelsus is used in the treatment of Type 2 Diabetes and belongs to the drug class GLP-1 Agonists (Incretin Mimetics). Rybelsus 14 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for novo 14
Rybelsus (formulation R1)
- Generic Name
- semaglutide
- Imprint
- novo 14
- Strength
- 14 mg
- Color
- White
- Size
- 14.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- GLP-1 Agonists (Incretin Mimetics)
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Novo Nordisk
- National Drug Code (NDC)
- 00169-4314
See also:
More about Rybelsus (semaglutide)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (307)
- Drug images
- Latest FDA alerts (4)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: GLP-1 Agonists (Incretin Mimetics)
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.